Clinical Trials Browser

Phase 2 × Uveal Melanoma × glembatumumab vedotin × Clear all

NCT02363283 2020-08-21

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

Phase 2 Completed

37 enrolled 12 charts

Uveal Melanoma